Estimating Direct Cost of Cystic Fibrosis Care Using Irish Registry Healthcare Resource Utilisation Data, 2008 –2012

ConclusionsCFTR mutation is an important factor influencing the cost of CF care. Costs differ among cohorts of CF patients eligible to access new and emergingCFTR repair therapies. These findings support the evaluation of outcome-associated cost inCFTR mutation-specific CF patient groups.
Source: PharmacoEconomics - Category: Health Management Source Type: research